Philippe Solal‐Céligny

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene

Guillaume Cartron, Laurent Dacheux, Gilles Salles et al. · Blood · 2002 · 1.9K citations · Full text

Life Sciences, Cell Biology, Immunology +16

Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer

Guy Meyer, Zora Marjanovic, Judith Valcke et al. · Archives of Internal Medicine · 2002 · 802 citations

Medicine, Pharmacology, Pharmacotherapy +17

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

Massimo Federico, Monica Bellei, Luigi Marcheselli et al. · Journal of Clinical Oncology · 2009 · 751 citations · Full text

Medicine, Clinical Sciences, Oncology +14

Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.

Pauline Brice, Y Bastion, Éric Lepage et al. · Journal of Clinical Oncology · 1997 · 641 citations

Medicine, Hematology, Oncology +13

Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma

Robert Marcus, Kevin Imrie, Philippe Solal‐Céligny et al. · Journal of Clinical Oncology · 2008 · 592 citations

Medicine, Oncology, Pharmacotherapy +14